1:00 - 1:10 p.m.
Introduction: Cancer Care 2011: The Cost of Care in the U.S. and Its Impact
M. Gregg Bloche, MD, JD
Professor of Law, Georgetown University Law Center; Co-director, Georgetown/Johns Hopkins Joint Program in Law and Public Health
1:10 - 1:30 p.m.
Setting the Stage: $124 Billion Spent, to What Return?
Antonio Tito Fojo, MD, PhD
Head, Experimental Therapeutics Section
Senior Investigator, Medical Oncology Branch Affiliates, The Center for Cancer Research, National Cancer Institute, U.S. National Institutes of Health
1:30 - 1:50 p.m.
Bending the Cost Curve in Cancer
Thomas J. Smith, MD, FACP
Director of Palliative Medicine, Johns Hopkins Medical Institutions
Professor of Oncology, Sidney Kimmel Comprehensive Cancer Center
1:50 - 2:00 p.m.
Question & Answer Session
Moderator: John Marshall, MD
Director, Ruesch Center for the Cure of GI Cancers
Chief, Division of Hematology/Oncology
Associate Director, Georgetown Lombardi Comprehensive Cancer Center
2:00 - 2:15 p.m.
The Gatekeepers: Safety and Efficacy vs. Value
Gregory H. Reaman, MD
Associate Director, Office of Oncology Drug Products, Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
2:15- 2:30 p.m.
Jordan D. Berlin, MD
Professor of Medicine, Vanderbilt University School of Medicine
2:30 - 3:00 p.m.
Roundtable
Moderator: M. Gregg Bloche, JD, MD
Professor of Law, Georgetown University Law Center; Co-director, Georgetown/Johns Hopkins Joint Program in Law and Public Health
Private Insurance: Why Paying for Cancer Care Makes "Business" Sense
Ira Klein, MD, MBA, FACP
Chief of Staff, Office of the Chief Medical Officer
National Accounts Clinical Sales & Strategy, Aetna, Inc.
J. Russell Hoverman, MD, PhD
Vice President of Managed Care, Texas Oncology
Medical Director of Managed Care and Disease Management
The U.S. Oncology Network
Medicare/CMS: Unlimited Access vs. Governmental Controls
Louis Jacques, MD
Director, Coverage & Analysis Group, Office of Clinical Standards and Quality, Centers for Medicare & Medicaid Services, U.S. Department of Health & Human Services
3:15 - 4:00 p.m.
Measuring Value in Cancer: U.S. & Global
Moderator: Arnold Potosky, PhD
Director of Health Sciences Research, Georgetown Lombardi Comprehensive Cancer Center
Comparative Effectiveness in the U.S.
Paul J. Wallace, MD
Senior Vice President, Director, Center for Comparative Effectiveness Research, The Lewin Group
Global Perspective
Mona Sabharwal, BscPhm, PharmD, RPh
Executive Director, Pan-Canadian Oncology Drug Review
Value Decisions in Drug Development
Arthur "Art" Small, MD
Head, Oncology Outcomes Research, U.S. Medical Affairs, Biometrics, Health Outcomes & Payer Support, Genentech, Inc.
Defining Value: The Individual vs. the Group
Margaret "Mimi" Mahon, PhD, RN, FAAN
Palliative Care Nurse Practitioner
Associate Professor, School of Nursing, George Mason University, College of Health & Human Services
4:00 - 5:00 p.m.
Roundtable: The Stakeholders' Perspectives: What Do We Want in the Clinic?
Moderator: Ellen Sigal, PhD
Chairperson and Founder, Friends of Cancer Research
Featuring Ruesch Center Advocacy Board Members:
Carolyn R. "Bo" Aldigé
President and Founder, Prevent Cancer Foundation
Carlea Bauman
President, Fight Colorectal Cancer
Lucile Adams-Campbell, PhD
Associate Dean, Community Health and Outreach, Associate Director, Minority Health and Health Disparities Research, Georgetown Lombardi Comprehensive Cancer Center
Julie Fleshman, JD, MBA
President and Chief Executive Officer, Pancreatic Cancer Action Network
Morton "Morty" Funger
Chairman, Community Realty Company
Gilad Gordon, MD, MBA
President, ORRA Group, LLC
Jasmine Greenamyer
Chief Operating Officer, Colon Cancer Alliance
Mace Rothenberg, MD
Senior Vice President, Clinical Development & Medical Affairs, Oncology Business Unit, Pfizer, Inc.
Michael Sapienza
Executive Director and Chairman of the Board, Chris4Life Colon Cancer Foundation
The Honorable Peter Teeley
Advisor, Blackstreet Capital Management, LLC
Former U.S. Ambassador to Canada
Daniel Von Hoff, MD, FACP
Physician in Chief and Distinguished Professor, Translational Genomics Institute
Professor of Medicine, Mayo Clinic
Clinical Professor of Medicine, University of Arizona College of Medicine
Chief Scientific Officer, VGPCC Clinical Trial Program, Scottsdale Healthcare
|
